Menu
GeneBe

1-112647216-A-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_006135.3(CAPZA1):c.46A>G(p.Ile16Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,523,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

CAPZA1
NM_006135.3 missense

Scores

2
4
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.83
Variant links:
Genes affected
CAPZA1 (HGNC:1488): (capping actin protein of muscle Z-line subunit alpha 1) CAPZA1 is a member of the F-actin capping protein alpha subunit family. This gene encodes the alpha subunit of the barbed-end actin binding protein. The protein regulates growth of the actin filament by capping the barbed end of growing actin filaments. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.24661705).
BS2
High AC in GnomAd at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CAPZA1NM_006135.3 linkuse as main transcriptc.46A>G p.Ile16Val missense_variant 2/10 ENST00000263168.4
CAPZA1XM_017002424.3 linkuse as main transcriptc.46A>G p.Ile16Val missense_variant 2/10
CAPZA1XM_011542225.4 linkuse as main transcriptc.46A>G p.Ile16Val missense_variant 2/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CAPZA1ENST00000263168.4 linkuse as main transcriptc.46A>G p.Ile16Val missense_variant 2/101 NM_006135.3 P1
CAPZA1ENST00000476936.5 linkuse as main transcriptn.72A>G non_coding_transcript_exon_variant 2/83
CAPZA1ENST00000485542.5 linkuse as main transcriptn.86A>G non_coding_transcript_exon_variant 2/32
CAPZA1ENST00000498626.1 linkuse as main transcriptn.99A>G non_coding_transcript_exon_variant 3/95

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000436
AC:
10
AN:
229506
Hom.:
0
AF XY:
0.0000481
AC XY:
6
AN XY:
124696
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000379
Gnomad FIN exome
AF:
0.0000472
Gnomad NFE exome
AF:
0.0000748
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000107
AC:
146
AN:
1370738
Hom.:
0
Cov.:
26
AF XY:
0.0000956
AC XY:
65
AN XY:
680112
show subpopulations
Gnomad4 AFR exome
AF:
0.0000318
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000423
Gnomad4 FIN exome
AF:
0.0000602
Gnomad4 NFE exome
AF:
0.000131
Gnomad4 OTH exome
AF:
0.0000179
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152328
Hom.:
0
Cov.:
32
AF XY:
0.0000940
AC XY:
7
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000565
Hom.:
0
Bravo
AF:
0.0000529
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000659
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 06, 2022The c.46A>G (p.I16V) alteration is located in exon 2 (coding exon 2) of the CAPZA1 gene. This alteration results from a A to G substitution at nucleotide position 46, causing the isoleucine (I) at amino acid position 16 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.063
T
BayesDel_noAF
Benign
-0.15
Cadd
Uncertain
24
Dann
Uncertain
1.0
DEOGEN2
Benign
0.095
T
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.25
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.9
L
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-0.78
N
REVEL
Benign
0.28
Sift
Uncertain
0.018
D
Sift4G
Benign
0.22
T
Polyphen
0.0020
B
Vest4
0.59
MVP
0.48
MPC
0.25
ClinPred
0.097
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.38
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369340611; hg19: chr1-113189838; API